Another Cuban COVID-19 vaccine candidate goes to phase II of clinical trials
The Cuban Abdala COVID-19 vaccine candidate will begin the second phase of clinical trials on February 1, the official media reported. In this way, the also named CIGB 66 will become the second vaccine project produced on the island to move to this phase of studies, after Soberana 02 did it last December. Phase II […]
La entrada Another Cuban COVID-19 vaccine candidate goes to phase II of clinical trials se publicó primero en OnCubaNews English.
Comments for this post are closed.